Streetbeat News

Price Targets

RH

B of A Securities analyst Curtis Nagle maintains a Buy rating on RH (NYSE:RH) and raises the price target from $315 to $360.

Portfolio Pulse from richadhand@benzinga.com

June 29, 2023 | 1:41 pm

LYB

Wells Fargo analyst Michael Sison has maintained an Overweight rating on LyondellBasell Industries (NYSE:LYB) but lowered the price target from $109 to $100.

Portfolio Pulse from richadhand@benzinga.com

June 29, 2023 | 1:40 pm

OPEN

JMP Securities analyst Nicholas Jones maintains a Market Outperform rating on Opendoor Technologies (NASDAQ:OPEN) and raises the price target from $2.5 to $5.

Portfolio Pulse from richadhand@benzinga.com

June 29, 2023 | 1:38 pm

SNOW

Barclays analyst Raimo Lenschow maintains an Overweight rating on Snowflake (NYSE:SNOW) and raises the price target from $165 to $203.

Portfolio Pulse from richadhand@benzinga.com

June 29, 2023 | 1:37 pm

MU

Barclays analyst Tom O'Malley has maintained an Overweight rating on Micron Technology (NASDAQ:MU) and raised the price target from $70 to $75.

Portfolio Pulse from richadhand@benzinga.com

June 29, 2023 | 1:36 pm

BILL

Deutsche Bank analyst Bryan Keane maintains a Buy rating on BILL Holdings (NYSE:BILL) and raises the price target from $110 to $140.

Portfolio Pulse from richadhand@benzinga.com

June 29, 2023 | 1:34 pm

GNTA

Roth MKM analyst Kumaraguru Raja has assumed Genenta Science (NASDAQ:GNTA) with a Buy rating and set a price target of $15.

Portfolio Pulse from richadhand@benzinga.com

June 29, 2023 | 1:21 pm

CZFS

Janney Montgomery Scott analyst Jake Civiello has downgraded Citizens Financial Servs (NASDAQ:CZFS) from Buy to Neutral and set a price target of $80.

Portfolio Pulse from richadhand@benzinga.com

June 29, 2023 | 1:19 pm

FC

Barrington Research analyst Alexander Paris has reiterated an 'Outperform' rating on Franklin Covey (NYSE:FC) and maintained a $55 price target.

Portfolio Pulse from richadhand@benzinga.com

June 29, 2023 | 1:03 pm

OPK

Barrington Research analyst Michael Petusky has upgraded OPKO Health (NASDAQ:OPK) from Market Perform to Outperform and set a price target of $2.

Portfolio Pulse from richadhand@benzinga.com

June 29, 2023 | 1:02 pm